Renu Garg
Adolescent Medicine · Houston, TXNPI 1457360992
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.
Across 88 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$410
- Cranial Technologies, Inc$291
- Tris Pharma Inc$249
- Merck$155
- Sanofi Pasteur Inc.$135
- Organon$124
- plus $593 from 14 others
Across 97 payments — averaging $11,495 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$1.1M
What the payments were for
- Food & beverage$1,958100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 18 | $410 |
| Cranial Technologies, Inc | 21 | $291 |
| Tris Pharma Inc | 2 | $249 |
| Merck | 9 | $155 |
| Sanofi Pasteur Inc. | 6 | $135 |
| Organon | 1 | $124 |
| Corium, LLC | 5 | $103 |
| Phadia US Inc. | 5 | $93 |
| Pfizer | 4 | $86 |
| Supernus Pharmaceuticals, Inc. | 4 | $82 |
| Seqirus USA Inc | 3 | $50 |
| Cumberland Pharmaceuticals, Inc. | 2 | $36 |
| Cipher Pharmaceuticals US LLC | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $24 |
| AstraZeneca | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $13 |
| Verrica Pharmaceuticals Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$249
- VTAMA$124
How this compares
$1,958 in reported general payments places this provider in the 80th percentile of 68 adolescent medicine providers in Texas.
Other adolescent medicine in Houston
- Amy MiddlemanHouston$70K
- Surainder AjmaniHouston$3K
- Sharonda TaylorHouston$2K
- Michael FunkeHouston$2K
- Shannon HayesHouston$2K
- Cornelius WilsonHouston$678
- Syed RizviHouston$549
- Mona EissaHouston$410
- Laura BenjaminsHouston$230
- Surinder KaulHouston$155
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.